{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T05:08:27Z","timestamp":1784783307112,"version":"3.55.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:00:00Z","timestamp":1745366400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"College Student Innovation and Entrepreneurship Project","award":["No.202410201010"],"award-info":[{"award-number":["No.202410201010"]}]},{"name":"College Student Innovation and Entrepreneurship Project","award":["No.S202410201083"],"award-info":[{"award-number":["No.S202410201083"]}]},{"name":"Graduate Innovation Project of Beihua University","award":["No. 2024021"],"award-info":[{"award-number":["No. 2024021"]}]},{"name":"Graduate Innovation Project of Beihua University","award":["No. 2024066"],"award-info":[{"award-number":["No. 2024066"]}]},{"DOI":"10.13039\/501100011789","name":"Jilin Provincial Department of Science and Technology","doi-asserted-by":"crossref","award":["No.YDZJ202201ZYTS194"],"award-info":[{"award-number":["No.YDZJ202201ZYTS194"]}],"id":[{"id":"10.13039\/501100011789","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04497-z","type":"journal-article","created":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T05:00:05Z","timestamp":1745384405000},"page":"3481-3497","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mechanisms and progress of LncRNAs in prostate cancer development and diagnostic therapy"],"prefix":"10.1007","volume":"57","author":[{"given":"Shihan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanbo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongrui","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,23]]},"reference":[{"issue":"3","key":"4497_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H et al (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Cancer J Clin 74(3):229\u2013263","journal-title":"Cancer J Clin"},{"issue":"3","key":"4497_CR2","first-page":"221","volume":"46","author":"RS Zheng","year":"2024","unstructured":"Zheng RS, Chen R, Han BF et al (2024) Cancer incidence and mortality in China, 2022]. Zhonghua zhong liu za zhi [Chinese journal of oncology] 46(3):221\u2013231","journal-title":"Zhonghua zhong liu za zhi [Chinese journal of oncology]"},{"issue":"2","key":"4497_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, Pekala KR, Matsoukas K et al (2023) 2022 update on prostate cancer epidemiology and risk factors-A systematic review. Eur Urol 84(2):191\u2013206","journal-title":"Eur Urol"},{"issue":"7","key":"4497_CR4","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/S1470-2045(20)30349-1","volume":"21","author":"Elizabeth Gourd","year":"2020","unstructured":"Gourd E (2020) New advances in prostate cancer screening and monitoring. Lancet Oncol 21(7):887","journal-title":"Lancet Oncol"},{"issue":"1","key":"4497_CR5","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41572-020-00243-0","volume":"7","author":"RJ Rebello","year":"2021","unstructured":"Rebello RJ, Oing C, Knudsen KE et al (2021) Prostate cancer. Nature Rev Dis Prim 7(1):9","journal-title":"Nature Rev Dis Prim"},{"issue":"10","key":"4497_CR6","first-page":"1065","volume":"51","author":"LJ Wang","year":"2022","unstructured":"Wang LJ, Pei F (2022) Research advances on prostate cancer related genes. Zhonghua bing li xue za zhi. Chinese J Pathol 51(10):1065\u20131068","journal-title":"Chinese J Pathol"},{"issue":"3","key":"4497_CR7","first-page":"231","volume":"71","author":"J Mayor de Castro","year":"2018","unstructured":"Mayor de Castro J, Ca\u00f1o Velasco J, Arag\u00f3n Chamizo J et al (2018) Locally advanced prostate cancer. Definition diagnosis and treatment. Arch Esp Urol 71(3):231\u2013238","journal-title":"Arch Esp Urol"},{"key":"4497_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27175730","author":"M Sekhoacha","year":"2022","unstructured":"Sekhoacha M, Riet K, Motloung P et al (2022) Prostate cancer review: genetics, diagnosis, treatment options, and alternative approaches. Molecul Basel. https:\/\/doi.org\/10.3390\/molecules27175730","journal-title":"Molecul Basel"},{"issue":"10","key":"4497_CR9","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-017729","volume":"7","author":"GJ Young","year":"2017","unstructured":"Young GJ, Harrison S, Turner EL et al (2017) Prostate-specific antigen (PSA) testing of men in UK general practice: a 10-year longitudinal cohort study. BMJ Open 7(10):e017729","journal-title":"BMJ Open"},{"issue":"11","key":"4497_CR10","first-page":"740","volume":"98","author":"YC Chang","year":"1999","unstructured":"Chang YC, Huang KM, Chen JH et al (1999) Impact of magnetic resonance imaging on the advancement of medicine. J Form Med Associat Taiwan yi zhi 98(11):740\u2013748","journal-title":"J Form Med Associat Taiwan yi zhi"},{"issue":"6","key":"4497_CR11","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1053\/j.semnuclmed.2016.07.002","volume":"46","author":"M Nguyen-Nielsen","year":"2016","unstructured":"Nguyen-Nielsen M, Borre M (2016) Diagnostic and therapeutic strategies for prostate cancer. Semin Nucl Med 46(6):484\u2013490","journal-title":"Semin Nucl Med"},{"issue":"1","key":"4497_CR12","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.eururo.2022.03.002","volume":"82","author":"HA De Barros","year":"2022","unstructured":"De Barros HA, Van Oosterom MN, Donswijk ML et al (2022) Robot-assisted prostate-specific membrane antigen-radioguided salvage surgery in recurrent prostate cancer using a DROP-IN gamma probe: the first prospective feasibility study. Eur Urol 82(1):97\u2013105","journal-title":"Eur Urol"},{"key":"4497_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2022.100912","volume":"67","author":"N Zhang","year":"2023","unstructured":"Zhang N, Huang D, Ruan X et al (2023) CRISPR screening reveals gleason score and castration resistance related oncodriver ring finger protein 19 A (RNF19A) in prostate cancer. Drug Resist Updat 67:100912","journal-title":"Drug Resist Updat"},{"key":"4497_CR14","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.ade4656","author":"Y Zhu","year":"2023","unstructured":"Zhu Y, Zhao Y, Wen J et al (2023) Targeting the chromatin effector Pygo2 promotes cytotoxic T cell responses and overcomes immunotherapy resistance in prostate cancer. Sci Immunol. https:\/\/doi.org\/10.1126\/sciimmunol.ade4656","journal-title":"Sci Immunol"},{"issue":"1","key":"4497_CR15","volume":"1873","author":"SC Gupta","year":"2020","unstructured":"Gupta SC, Awasthee N, Rai V et al (2020) Long non-coding RNAs and nuclear factor-\u03baB crosstalk in cancer and other human diseases. Biochim Biophys Acta 1873(1):188316","journal-title":"Biochim Biophys Acta"},{"issue":"2","key":"4497_CR16","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.canlet.2013.06.013","volume":"339","author":"X Shi","year":"2013","unstructured":"Shi X, Sun M, Liu H et al (2013) Long non-coding RNAs: a new frontier in the study of human diseases. Cancer Lett 339(2):159\u2013166","journal-title":"Cancer Lett"},{"issue":"43","key":"4497_CR17","doi-asserted-by":"publisher","first-page":"4577","DOI":"10.1038\/onc.2011.621","volume":"31","author":"R Spizzo","year":"2012","unstructured":"Spizzo R, Almeida MI, Colombatti A et al (2012) Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene 31(43):4577\u20134587","journal-title":"Oncogene"},{"issue":"6","key":"4497_CR18","doi-asserted-by":"publisher","first-page":"9605","DOI":"10.1002\/jcp.27647","volume":"234","author":"T Yao","year":"2019","unstructured":"Yao T, Lu R, Zhang J et al (2019) Growth arrest-specific 5 attenuates cisplatin-induced apoptosis in cervical cancer by regulating STAT3 signaling via miR-21. J Cell Physiol 234(6):9605\u20139615","journal-title":"J Cell Physiol"},{"key":"4497_CR19","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154991","volume":"253","author":"AA Bhat","year":"2024","unstructured":"Bhat AA, Afzal O, Afzal M et al (2024) MALAT1: A key regulator in lung cancer pathogenesis and therapeutic targeting. Pathol Res Pract 253:154991","journal-title":"Pathol Res Pract"},{"issue":"6","key":"4497_CR20","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1002\/1878-0261.12666","volume":"14","author":"R Shang","year":"2020","unstructured":"Shang R, Wang M, Dai B et al (2020) Long noncoding RNA SLC2A1-AS1 regulates aerobic glycolysis and progression in hepatocellular carcinoma via inhibiting the STAT3\/FOXM1\/GLUT1 pathway. Mol Oncol 14(6):1381\u20131396","journal-title":"Mol Oncol"},{"issue":"1","key":"4497_CR21","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1038\/s41467-023-37871-5","volume":"14","author":"XY He","year":"2023","unstructured":"He XY, Fan X, Qu L et al (2023) LncRNA modulates Hippo-YAP signaling to reprogram iron metabolism. Nat Commun 14(1):2253","journal-title":"Nat Commun"},{"issue":"2","key":"4497_CR22","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL et al (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"4497_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/s41580-022-00566-8","volume":"24","author":"JS Mattick","year":"2023","unstructured":"Mattick JS, Amaral PP, Carninci P et al (2023) Long non-coding RNAs: definitions, functions, challenges and recommendations. Nat Rev Mol Cell Biol 24(6):430\u2013447","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"4497_CR24","first-page":"25","volume":"2","author":"Z Wang","year":"2013","unstructured":"Wang Z, Li X (2013) The role of noncoding RNA in hepatocellular carcinoma. Gland Surg 2(1):25\u201329","journal-title":"Gland Surg"},{"issue":"1","key":"4497_CR25","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13059-017-1293-0","volume":"18","author":"H Hezroni","year":"2017","unstructured":"Hezroni H, Ben-Tov Perry R, Meir Z et al (2017) A subset of conserved mammalian long non-coding RNAs are fossils of ancestral protein-coding genes. Genome Biol 18(1):162","journal-title":"Genome Biol"},{"issue":"7","key":"4497_CR26","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1016\/j.cell.2007.05.022","volume":"129","author":"JL Rinn","year":"2007","unstructured":"Rinn JL, Kertesz M, Wang JK et al (2007) Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell 129(7):1311\u20131323","journal-title":"Cell"},{"key":"4497_CR27","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna5010017","author":"JCR Fernandes","year":"2019","unstructured":"Fernandes JCR, Acu\u00f1a SM, Aoki JI et al (2019) Long non-coding RNAs in the regulation of gene expression: physiology and disease. Non-Coding RNA. https:\/\/doi.org\/10.3390\/ncrna5010017","journal-title":"Non-Coding RNA"},{"issue":"2","key":"4497_CR28","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s00424-021-02641-z","volume":"474","author":"JA Oo","year":"2022","unstructured":"Oo JA, Brandes RP, Leisegang MS (2022) Long non-coding RNAs: novel regulators of cellular physiology and function. Pflugers Arch 474(2):191\u2013204","journal-title":"Pflugers Arch"},{"key":"4497_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ncrna6040049","author":"HR Pinkney","year":"2020","unstructured":"Pinkney HR, Wright BM, Diermeier SD (2020) The lncRNA toolkit databases and in silico tools for lncRNA analysis. Non-coding RNA. https:\/\/doi.org\/10.3390\/ncrna6040049","journal-title":"Non-coding RNA"},{"issue":"1","key":"4497_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/0008-5472.CAN-10-2483","volume":"71","author":"MC Tsai","year":"2011","unstructured":"Tsai MC, Spitale RC, Chang HY (2011) Long intergenic noncoding RNAs: new links in cancer progression. Cancer Res 71(1):3\u20137","journal-title":"Cancer Res"},{"issue":"11","key":"4497_CR31","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1111\/cas.13352","volume":"108","author":"A Misawa","year":"2017","unstructured":"Misawa A, Takayama KI, Inoue S (2017) Long non-coding RNAs and prostate cancer. Cancer Sci 108(11):2107\u20132114","journal-title":"Cancer Sci"},{"issue":"16","key":"4497_CR32","doi-asserted-by":"publisher","first-page":"3766","DOI":"10.1111\/febs.12902","volume":"281","author":"M Zhu","year":"2014","unstructured":"Zhu M, Chen Q, Liu X et al (2014) lncRNA H19\/miR-675 axis represses prostate cancer metastasis by targeting TGFBI. FEBS J 281(16):3766\u20133775","journal-title":"FEBS J"},{"issue":"3","key":"4497_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/ng.3192","volume":"47","author":"MK Iyer","year":"2015","unstructured":"Iyer MK, Niknafs YS, Malik R et al (2015) The landscape of long noncoding RNAs in the human transcriptome. Nat Genet 47(3):199\u2013208","journal-title":"Nat Genet"},{"issue":"6","key":"4497_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.426","volume":"11","author":"C Lang","year":"2021","unstructured":"Lang C, Yin C, Lin K et al (2021) m(6) A modification of lncRNA PCAT6 promotes bone metastasis in prostate cancer through IGF2BP2-mediated IGF1R mRNA stabilization. Clin Transl Med 11(6):e426","journal-title":"Clin Transl Med"},{"key":"4497_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2023.154666","author":"R Haghighi","year":"2023","unstructured":"Haghighi R, Castillo-Acobo RY et al (2023) A thorough understanding of the role of lncRNA in prostate cancer pathogenesis Current knowledge and future research directions. Pathol Res Pract. https:\/\/doi.org\/10.1016\/j.prp.2023.154666","journal-title":"Pathol Res Pract"},{"issue":"1","key":"4497_CR36","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1186\/s13046-023-02774-2","volume":"42","author":"Q Dong","year":"2023","unstructured":"Dong Q, Qiu H, Piao C et al (2023) LncRNA SNHG4 promotes prostate cancer cell survival and resistance to enzalutamide through a let-7a\/RREB1 positive feedback loop and a ceRNA network. J Experimen Clin Cancer Res 42(1):209","journal-title":"J Experimen Clin Cancer Res"},{"issue":"7766","key":"4497_CR37","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1038\/s41586-019-1411-0","volume":"571","author":"G Cavalli","year":"2019","unstructured":"Cavalli G, Heard E (2019) Advances in epigenetics link genetics to the environment and disease. Nature 571(7766):489\u2013499","journal-title":"Nature"},{"issue":"3","key":"4497_CR38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.gpb.2016.12.005","volume":"15","author":"IM Dykes","year":"2017","unstructured":"Dykes IM, Emanueli C (2017) Transcriptional and post-transcriptional gene regulation by long non-coding RNA. Genom Proteom Bioinform 15(3):177\u2013186","journal-title":"Genom Proteom Bioinform"},{"issue":"11","key":"4497_CR39","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1002\/pros.23538","volume":"78","author":"H Bayat","year":"2018","unstructured":"Bayat H, Narouie B, Ziaee SM et al (2018) Two long non-coding RNAs, Prcat173 and Prcat38, could efficiently discriminate benign prostate hyperplasia from prostate cancer. Prostate 78(11):812\u2013818","journal-title":"Prostate"},{"key":"4497_CR40","doi-asserted-by":"publisher","DOI":"10.3390\/cells8080864","author":"Z Chen","year":"2019","unstructured":"Chen Z, Song X, Li Q et al (2019) Androgen receptor-activated enhancers simultaneously regulate oncogene TMPRSS2 and lncRNA PRCAT38 in prostate cancer. Cells. https:\/\/doi.org\/10.3390\/cells8080864","journal-title":"Cells"},{"issue":"2","key":"4497_CR41","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1016\/j.bbrc.2018.05.157","volume":"502","author":"X Yang","year":"2018","unstructured":"Yang X, Wang L, Li R et al (2018) The long non-coding RNA PCSEAT exhibits an oncogenic property in prostate cancer and functions as a competing endogenous RNA that associates with EZH2. Biochem Biophys Res Commun 502(2):262\u2013268","journal-title":"Biochem Biophys Res Commun"},{"issue":"34","key":"4497_CR42","doi-asserted-by":"publisher","first-page":"17861","DOI":"10.1074\/jbc.M116.718536","volume":"291","author":"A Misawa","year":"2016","unstructured":"Misawa A, Takayama K, Urano T et al (2016) Androgen-induced long noncoding RNA (lncRNA) SOCS2-AS1 promotes cell growth and inhibits apoptosis in prostate cancer cells. J Biol Chem 291(34):17861\u201317880","journal-title":"J Biol Chem"},{"issue":"10","key":"4497_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/s41419-021-04144-2","volume":"12","author":"B Zhang","year":"2021","unstructured":"Zhang B, Zhang M, Shen C et al (2021) LncRNA PCBP1-AS1-mediated AR\/AR-V7 deubiquitination enhances prostate cancer enzalutamide resistance. Cell Death Dis 12(10):856","journal-title":"Cell Death Dis"},{"issue":"1","key":"4497_CR44","doi-asserted-by":"publisher","first-page":"23356","DOI":"10.1038\/s41598-021-02642-z","volume":"11","author":"S Huang","year":"2021","unstructured":"Huang S, Luo K, Jiang L et al (2021) PCBP1 regulates the transcription and alternative splicing of metastasis-related genes and pathways in hepatocellular carcinoma. Sci Rep 11(1):23356","journal-title":"Sci Rep"},{"issue":"23","key":"4497_CR45","first-page":"5975","volume":"59","author":"MJ Bussemakers","year":"1999","unstructured":"Bussemakers MJ, van Bokhoven A, Verhaegh GW et al (1999) DD3: a new prostate-specific gene, highly overexpressed in prostate cancer. Can Res 59(23):5975\u20135979","journal-title":"Can Res"},{"issue":"8","key":"4497_CR46","doi-asserted-by":"publisher","first-page":"11339","DOI":"10.1007\/s13277-016-5012-3","volume":"37","author":"AE Lemos","year":"2016","unstructured":"Lemos AE, Ferreira LB, Batoreu NM et al (2016) PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells. Tumour Biol 37(8):11339\u201311348","journal-title":"Tumour Biol"},{"key":"4497_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2022.153800","volume":"231","author":"S Ghafouri-Fard","year":"2022","unstructured":"Ghafouri-Fard S, Khoshbakht T, Hussen BM et al (2022) A review on the role of PCA3 lncRNA in carcinogenesis with an especial focus on prostate cancer. Pathol Res Pract 231:153800","journal-title":"Pathol Res Pract"},{"key":"4497_CR48","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/1471-2407-12-507","volume":"12","author":"LB Ferreira","year":"2012","unstructured":"Ferreira LB, Palumbo A, Mello DE, K D, et al (2012) PCA3 noncoding RNA is involved in the control of prostate-cancer cell survival and modulates androgen receptor signaling. BMC Cancer 12:507","journal-title":"BMC Cancer"},{"issue":"1","key":"4497_CR49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.eururo.2015.04.039","volume":"70","author":"SA Tomlins","year":"2016","unstructured":"Tomlins SA, Day JR, Lonigro RJ et al (2016) Urine TMPRSS2:ERG Plus PCA3 for individualized prostate cancer risk assessment. Eur Urol 70(1):45\u201353","journal-title":"Eur Urol"},{"issue":"1","key":"4497_CR50","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1158\/0008-5472.CAN-20-3845","volume":"82","author":"R Ghildiyal","year":"2022","unstructured":"Ghildiyal R, Sawant M, Renganathan A et al (2022) Loss of long noncoding RNA NXTAR in prostate cancer augments androgen receptor expression and enzalutamide resistance. Can Res 82(1):155\u2013168","journal-title":"Can Res"},{"issue":"3","key":"4497_CR51","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1128\/MCB.19.3.1810","volume":"19","author":"A Masumi","year":"1999","unstructured":"Masumi A, Wang IM, Lefebvre B et al (1999) The histone acetylase PCAF is a phorbol-ester-inducible coactivator of the IRF family that confers enhanced interferon responsiveness. Mol Cell Biol 19(3):1810\u20131820","journal-title":"Mol Cell Biol"},{"key":"4497_CR52","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/B978-0-12-801105-8.00007-2","volume":"116","author":"B Guennewig","year":"2014","unstructured":"Guennewig B, Cooper AA (2014) The central role of noncoding RNA in the brain. Int Rev Neurobiol 116:153\u2013194","journal-title":"Int Rev Neurobiol"},{"issue":"10","key":"4497_CR53","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1038\/s41419-021-03966-4","volume":"12","author":"M Zhang","year":"2021","unstructured":"Zhang M, Sun Y, Huang CP et al (2021) Targeting the Lnc-OPHN1-5\/androgen receptor\/hnRNPA1 complex increases Enzalutamide sensitivity to better suppress prostate cancer progression. Cell Death Dis 12(10):855","journal-title":"Cell Death Dis"},{"issue":"1","key":"4497_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-019-1037-8","volume":"18","author":"P Gu","year":"2019","unstructured":"Gu P, Chen X, Xie R et al (2019) A novel AR translational regulator lncRNA LBCS inhibits castration resistance of prostate cancer. Mol Cancer 18(1):109","journal-title":"Mol Cancer"},{"key":"4497_CR55","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/896206","volume":"2014","author":"R Sen","year":"2014","unstructured":"Sen R, Ghosal S, Das S et al (2014) Competing endogenous RNA: the key to posttranscriptional regulation. TheScientificWorldJOURNAL 2014:896206","journal-title":"TheScientificWorldJOURNAL"},{"issue":"2","key":"4497_CR56","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1016\/j.bbrc.2018.01.097","volume":"496","author":"H Wu","year":"2018","unstructured":"Wu H, Zhou C (2018) Long non-coding RNA UCA1 promotes lung cancer cell proliferation and migration via microRNA-193a\/HMGB1 axis. Biochem Biophys Res Commun 496(2):738\u2013745","journal-title":"Biochem Biophys Res Commun"},{"issue":"2","key":"4497_CR57","first-page":"366","volume":"9","author":"S Zhang","year":"2017","unstructured":"Zhang S, Dong X, Ji T et al (2017) Long non-coding RNA UCA1 promotes cell progression by acting as a competing endogenous RNA of ATF2 in prostate cancer. Amer J Translat Res 9(2):366\u2013375","journal-title":"Amer J Translat Res"},{"key":"4497_CR58","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20181465","author":"C He","year":"2019","unstructured":"He C, Lu X, Yang F et al (2019) LncRNA UCA1 acts as a sponge of miR-204 to up-regulate CXCR4 expression and promote prostate cancer progression. Biosci Report. https:\/\/doi.org\/10.1042\/BSR20181465"},{"key":"4497_CR59","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.omtn.2019.11.021","volume":"19","author":"Y Yu","year":"2020","unstructured":"Yu Y, Gao F, He Q et al (2020) lncRNA UCA1 functions as a ceRNA to promote prostate cancer progression via sponging miR143. Mole Ther Nucl Acid 19:751\u2013758","journal-title":"Mole Ther Nucl Acid"},{"key":"4497_CR60","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1186\/s12935-020-01538-8","volume":"20","author":"M Hu","year":"2020","unstructured":"Hu M, Yang J (2020) Down-regulation of lncRNA UCA1 enhances radiosensitivity in prostate cancer by suppressing EIF4G1 expression via sponging miR-331-3p. Cancer Cell Int 20:449","journal-title":"Cancer Cell Int"},{"key":"4497_CR61","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-024-01355-7","author":"XP Fu","year":"2024","unstructured":"Fu XP, Ji CY, Tang WQ et al (2024) Long non-coding RNA LOXL1-AS1: a potential biomarker and therapeutic target in human malignant tumors. Clin Experim Med. https:\/\/doi.org\/10.1007\/s10238-024-01355-7","journal-title":"Clin Experim Med"},{"issue":"2","key":"4497_CR62","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.bbrc.2018.09.160","volume":"505","author":"B Long","year":"2018","unstructured":"Long B, Li N, Xu XX et al (2018) Long noncoding RNA LOXL1-AS1 regulates prostate cancer cell proliferation and cell cycle progression through miR-541-3p and CCND1. Biochem Biophys Res Commun 505(2):561\u2013568","journal-title":"Biochem Biophys Res Commun"},{"issue":"10","key":"4497_CR63","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1002\/iub.2075","volume":"71","author":"T Bai","year":"2019","unstructured":"Bai T, Liu Y, Li B (2019) LncRNA LOXL1-AS1\/miR-let-7a-5p\/EGFR-related pathway regulates the doxorubicin resistance of prostate cancer DU-145 cells. IUBMB Life 71(10):1537\u20131551","journal-title":"IUBMB Life"},{"issue":"10","key":"4497_CR64","doi-asserted-by":"publisher","first-page":"2170","DOI":"10.1002\/cbin.11411","volume":"44","author":"M Gao","year":"2020","unstructured":"Gao M, Guo L, Wang H et al (2020) Orphan nuclear receptor ROR\u03b3 confers doxorubicin resistance in prostate cancer. Cell Biol Int 44(10):2170\u20132176","journal-title":"Cell Biol Int"},{"issue":"2","key":"4497_CR65","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3892\/ol.2022.13401","volume":"24","author":"M Hu","year":"2022","unstructured":"Hu M, Ren M, Zhao Z et al (2022) Long non-coding RNA SNHG3 promotes prostate cancer progression by sponging microRNA-1827. Oncol Lett 24(2):281","journal-title":"Oncol Lett"},{"issue":"1","key":"4497_CR66","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s11658-022-00313-z","volume":"27","author":"X Wang","year":"2022","unstructured":"Wang X, Song Y, Shi Y et al (2022) SNHG3 could promote prostate cancer progression through reducing methionine dependence of PCa cells. Cell Mol Biol Lett 27(1):13","journal-title":"Cell Mol Biol Lett"},{"issue":"Pt 2","key":"4497_CR67","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.129635","volume":"260","author":"Y Yao","year":"2024","unstructured":"Yao Y, Chen X, Wang X et al (2024) Glycolysis related lncRNA SNHG3 \/ miR-139-5p \/ PKM2 axis promotes castration-resistant prostate cancer (CRPC) development and enzalutamide resistance. Int J Biol Macromol 260(Pt 2):129635","journal-title":"Int J Biol Macromol"},{"issue":"6","key":"4497_CR68","first-page":"451","volume":"37","author":"L Yu","year":"2022","unstructured":"Yu L, Ren Y (2022) Long noncoding RNA small nucleolar RNA host gene 3 mediates prostate cancer migration, invasion, and epithelial-mesenchymal transition by sponging miR-487a-3p to regulate TRIM25. Cancer Biother Radiopharm 37(6):451\u2013465","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"4497_CR69","doi-asserted-by":"publisher","first-page":"1895","DOI":"10.1080\/21655979.2021.2020393","volume":"13","author":"X Xi","year":"2022","unstructured":"Xi X, Hu Z, Wu Q et al (2022) High expression of small nucleolar RNA host gene 3 predicts poor prognosis and promotes bone metastasis in prostate cancer by activating transforming growth factor-beta signaling. Bioengineered 13(1):1895\u20131907","journal-title":"Bioengineered"},{"issue":"Pt 4","key":"4497_CR70","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2025.141817","volume":"306","author":"B Li","year":"2025","unstructured":"Li B, Li H, Cheng X et al (2025) Long non-coding RNA LINC01232 promotes malignancy of prostate cancer through regulation of miR-181a-5p\/IRS2 pathway: Ki-67 protein molecular structure and function. Int J Biol Macromol 306(Pt 4):141817","journal-title":"Int J Biol Macromol"},{"issue":"8","key":"4497_CR71","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0198055","volume":"13","author":"Y Ye","year":"2018","unstructured":"Ye Y, Li SL, Wang SY (2018) Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer. PLoS ONE 13(8):e0198055","journal-title":"PLoS ONE"},{"issue":"3","key":"4497_CR72","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s00432-025-06153-6","volume":"151","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Zhang Z, Zheng Y et al (2025) LncRNA LINC01128 promotes prostate cancer cell proliferation, metastasis, and epithelial-mesenchymal transition by modulating miR-27b-3p. J Cancer Res Clin Oncol 151(3):98","journal-title":"J Cancer Res Clin Oncol"},{"key":"4497_CR73","doi-asserted-by":"publisher","DOI":"10.1007\/s12672-024-00931-3","author":"L Cheng","year":"2024","unstructured":"Cheng L, Li S, Jiang D et al (2024) DSCAM-AS1 promotes the development of prostate cancer. Discover Oncol. https:\/\/doi.org\/10.1007\/s12672-024-00931-3","journal-title":"Discover Oncol"},{"issue":"1","key":"4497_CR74","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s00432-024-06046-0","volume":"151","author":"Y Yu","year":"2024","unstructured":"Yu Y, He N, Song Z et al (2024) LIMD1-AS1 promotes the progression of prostate cancer and affects the function of prostate cancer cells by down-regulating miR-29c-3p. J Cancer Res Clin Oncol 151(1):5","journal-title":"J Cancer Res Clin Oncol"},{"key":"4497_CR75","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-022-02779-5","author":"Q Li","year":"2022","unstructured":"Li Q, Chen B, Song G et al (2022) Integrated analysis to identify the AC0051546\/hsa-miR-29c-3p\/CCNL2 axis as a novel prognostic biomarker associated with immune infiltration in prostate cancer. Cancer Cell Internat. https:\/\/doi.org\/10.1186\/s12935-022-02779-5","journal-title":"Cancer Cell Internat"},{"key":"4497_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.991165","author":"J Yu","year":"2022","unstructured":"Yu J, Tang R, Li J (2022) Identification of pyroptosis-related lncRNA signature and AC005253.1 as a pyroptosis-related oncogene in prostate cancer. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2022.991165","journal-title":"Front Oncol"},{"issue":"4","key":"4497_CR77","doi-asserted-by":"publisher","first-page":"4053","DOI":"10.3892\/ol.2017.6682","volume":"14","author":"Z Liu","year":"2017","unstructured":"Liu Z, Wu C, Xie N et al (2017) Long non-coding RNA MEG3 inhibits the proliferation and metastasis of oral squamous cell carcinoma by regulating the WNT\/\u03b2-catenin signaling pathway. Oncol Lett 14(4):4053\u20134058","journal-title":"Oncol Lett"},{"issue":"6","key":"4497_CR78","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1159\/000438577","volume":"37","author":"G Luo","year":"2015","unstructured":"Luo G, Wang M, Wu X et al (2015) Long Non-Coding RNA MEG3 inhibits cell proliferation and induces apoptosis in prostate cancer. Cellular Physiol Biochem 37(6):2209\u20132220","journal-title":"Cellular Physiol Biochem"},{"issue":"1","key":"4497_CR79","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/jcmm.13658","volume":"23","author":"M Wu","year":"2019","unstructured":"Wu M, Huang Y, Chen T et al (2019) LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p\/QKI-5 axis. J Cell Mol Med 23(1):29\u201338","journal-title":"J Cell Mol Med"},{"issue":"3","key":"4497_CR80","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1093\/jb\/mvz097","volume":"167","author":"Y Zhou","year":"2020","unstructured":"Zhou Y, Yang H, Xia W et al (2020) LncRNA MEG3 inhibits the progression of prostate cancer by facilitating H3K27 trimethylation of EN2 through binding to EZH2. J Biochem 167(3):295\u2013301","journal-title":"J Biochem"},{"key":"4497_CR81","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16314","volume":"11","author":"J Cheng","year":"2023","unstructured":"Cheng J, Sun Y, Zhao H et al (2023) Niraparib restrains prostate cancer cell proliferation and metastasis and tumor growth in mice by regulating the lncRNA MEG3\/miR-181-5p\/GATA6 pathway. PeerJ 11:e16314","journal-title":"PeerJ"},{"key":"4497_CR82","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgaf009","author":"J Luo","year":"2025","unstructured":"Luo J, Tao H, Chen L et al (2025) LncRNA MEG3 suppresses prostate cancer progression by mediating macrophage polarization via the miR-148a-3p\/ARRDC3 signaling axis. Carcinogenesis. https:\/\/doi.org\/10.1093\/carcin\/bgaf009","journal-title":"Carcinogenesis"},{"issue":"8","key":"4497_CR83","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1038\/nbt.1914","volume":"29","author":"JR Prensner","year":"2011","unstructured":"Prensner JR, Iyer MK, Balbin OA et al (2011) Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol 29(8):742\u2013749","journal-title":"Nat Biotechnol"},{"issue":"8","key":"4497_CR84","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.7150\/jca.23685","volume":"9","author":"Q Yuan","year":"2018","unstructured":"Yuan Q, Chu H, Ge Y et al (2018) LncRNA PCAT1 and its genetic variant rs1902432 are associated with prostate cancer risk. J Cancer 9(8):1414\u20131420","journal-title":"J Cancer"},{"key":"4497_CR85","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2017.09.019","author":"W Xu","year":"2017","unstructured":"Xu W, Chang J, Du X et al (2017) Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145\u20135p in prostate cancer. Biomed Pharmacother Pharma. https:\/\/doi.org\/10.1016\/j.biopha.2017.09.019","journal-title":"Biomed Pharmacother Pharma"},{"key":"4497_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.862015","volume":"12","author":"X Jiang","year":"2022","unstructured":"Jiang X, Guo S, Xu M et al (2022) TFAP2C-mediated lncRNA PCAT1 inhibits ferroptosis in docetaxel-resistant prostate cancer through c-Myc\/miR-25-3p\/SLC7A11 signaling. Front Oncol 12:862015","journal-title":"Front Oncol"},{"issue":"11","key":"4497_CR87","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.neo.2014.09.001","volume":"16","author":"JR Prensner","year":"2014","unstructured":"Prensner JR, Chen W, Han S et al (2014) The long non-coding RNA PCAT-1 promotes prostate cancer cell proliferation through cMyc. Neoplasia (New York, NY) 16(11):900\u2013908","journal-title":"Neoplasia (New York, NY)"},{"issue":"8","key":"4497_CR88","doi-asserted-by":"publisher","first-page":"4211","DOI":"10.1093\/nar\/gkz108","volume":"47","author":"Z Shang","year":"2019","unstructured":"Shang Z, Yu J, Sun L et al (2019) LncRNA PCAT1 activates AKT and NF-\u03baB signaling in castration-resistant prostate cancer by regulating the PHLPP\/FKBP51\/IKK\u03b1 complex. Nucleic Acids Res 47(8):4211\u20134225","journal-title":"Nucleic Acids Res"},{"issue":"12","key":"4497_CR89","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1002\/cam4.900","volume":"5","author":"HT Liu","year":"2016","unstructured":"Liu HT, Fang L, Cheng YX et al (2016) LncRNA PVT1 regulates prostate cancer cell growth by inducing the methylation of miR-146a. Cancer Med 5(12):3512\u20133519","journal-title":"Cancer Med"},{"issue":"12","key":"4497_CR90","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1080\/09168451.2017.1387048","volume":"81","author":"J Yang","year":"2017","unstructured":"Yang J, Li C, Mudd A et al (2017) LncRNA PVT1 predicts prognosis and regulates tumor growth in prostate cancer. Biosci Biotechn Biochem 81(12):2301\u20132306","journal-title":"Biosci Biotechn Biochem"},{"key":"4497_CR91","doi-asserted-by":"publisher","DOI":"10.3390\/genes10120964","author":"G Pal","year":"2019","unstructured":"Pal G, Huaman J, Levine F et al (2019) Long Noncoding RNA from PVT1 exon 9 Is overexpressed in prostate cancer and induces malignant transformation and castration resistance in prostate epithelial cells. Genes. https:\/\/doi.org\/10.3390\/genes10120964","journal-title":"Genes"},{"key":"4497_CR92","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1186\/s12935-020-01363-z","volume":"20","author":"H Wu","year":"2020","unstructured":"Wu H, Tian X, Zhu C (2020) Knockdown of lncRNA PVT1 inhibits prostate cancer progression in vitro and in vivo by the suppression of KIF23 through stimulating miR-15a-5p. Cancer Cell Int 20:283","journal-title":"Cancer Cell Int"},{"issue":"1","key":"4497_CR93","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12964-020-00691-x","volume":"19","author":"A Videira","year":"2021","unstructured":"Videira A, Beckedorff FC, Dasilva LF et al (2021) PVT1 signals an androgen-dependent transcriptional repression program in prostate cancer cells and a set of the repressed genes predicts high-risk tumors. Cell Commun Signal 19(1):5","journal-title":"Cell Commun Signal"},{"key":"4497_CR94","doi-asserted-by":"publisher","first-page":"305","DOI":"10.3389\/fonc.2017.00305","volume":"7","author":"A Cimadamore","year":"2017","unstructured":"Cimadamore A, Gasparrini S, Mazzucchelli R et al (2017) Long non-coding RNAs in prostate cancer with emphasis on second chromosome locus associated with prostate-1 expression. Front Oncol 7:305","journal-title":"Front Oncol"},{"issue":"4","key":"4497_CR95","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.eururo.2015.12.003","volume":"70","author":"R Mehra","year":"2016","unstructured":"Mehra R, Udager AM, Ahearn TU et al (2016) Overexpression of the long non-coding RNA SChLAP1 independently predicts lethal prostate cancer. Eur Urol 70(4):549\u2013552","journal-title":"Eur Urol"},{"issue":"2","key":"4497_CR96","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1038\/s41419-021-03455-8","volume":"12","author":"K Huang","year":"2021","unstructured":"Huang K, Tang Y (2021) SChLAP1 promotes prostate cancer development through interacting with EZH2 to mediate promoter methylation modification of multiple miRNAs of chromosome 5 with a DNMT3a-feedback loop. Cell Death Dis 12(2):188","journal-title":"Cell Death Dis"},{"issue":"1","key":"4497_CR97","doi-asserted-by":"publisher","first-page":"131","DOI":"10.3727\/096504017X14944585873631","volume":"26","author":"Y Li","year":"2018","unstructured":"Li Y, Luo H, Xiao N et al (2018) Long noncoding RNA SChLAP1 accelerates the proliferation and metastasis of prostate cancer via targeting miR-198 and promoting the MAPK1 pathway. Oncol Res 26(1):131\u2013143","journal-title":"Oncol Res"},{"issue":"9","key":"4497_CR98","doi-asserted-by":"publisher","first-page":"5073","DOI":"10.7314\/APJCP.2013.14.9.5073","volume":"14","author":"B Qi","year":"2013","unstructured":"Qi B, Yao WJ, Zhao BS et al (2013) Involvement of microRNA-198 overexpression in the poor prognosis of esophageal cancer. Asian Pac J Cancer Prevent 14(9):5073\u20135076","journal-title":"Asian Pac J Cancer Prevent"},{"issue":"1","key":"4497_CR99","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12957-019-1643-3","volume":"17","author":"Z Cui","year":"2019","unstructured":"Cui Z, Zheng X, Kong D (2019) Expression of Concern to: Decreased miR-198 expression and its prognostic significance in human gastric cancer. World J Surg Oncol 17(1):102","journal-title":"World J Surg Oncol"},{"issue":"21","key":"4497_CR100","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.1158\/1078-0432.CCR-12-3776","volume":"19","author":"C Marin-Muller","year":"2013","unstructured":"Marin-Muller C, Li D, Bharadwaj U et al (2013) A tumorigenic factor interactome connected through tumor suppressor microRNA-198 in human pancreatic cancer. Clin Cancer Res 19(21):5901\u20135913","journal-title":"Clin Cancer Res"},{"key":"4497_CR101","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.1038\/srep06145","volume":"4","author":"M Wang","year":"2014","unstructured":"Wang M, Wang J, Kong X et al (2014) MiR-198 represses tumor growth and metastasis in colorectal cancer by targeting fucosyl transferase 8. Sci Rep 4:6145","journal-title":"Sci Rep"},{"issue":"6","key":"4497_CR102","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.neo.2021.05.012","volume":"23","author":"SG Kidd","year":"2021","unstructured":"Kidd SG, Carm KT, Bogaard M et al (2021) High expression of SCHLAP1 in primary prostate cancer is an independent predictor of biochemical recurrence, despite substantial heterogeneity. Neoplasia (New York, NY) 23(6):634\u2013641","journal-title":"Neoplasia (New York, NY)"},{"key":"4497_CR103","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.28.635288","author":"M Oh","year":"2025","unstructured":"Oh M, Kadam RN, Charania ZS et al (2025) LncRNA SChLAP1 promotes cancer cell proliferation and invasion via its distinct structural domains and conserved regions. BioRxiv. https:\/\/doi.org\/10.1101\/2025.01.28.635288","journal-title":"BioRxiv"},{"key":"4497_CR104","doi-asserted-by":"publisher","first-page":"38414","DOI":"10.1038\/srep38414","volume":"6","author":"A Aiello","year":"2016","unstructured":"Aiello A, Bacci L, Re A et al (2016) MALAT1 and HOTAIR long non-coding rnas play opposite role in estrogen-mediated transcriptional regulation in prostate cancer cells. Sci Rep 6:38414","journal-title":"Sci Rep"},{"issue":"4","key":"4497_CR105","first-page":"3499","volume":"20","author":"X Dai","year":"2019","unstructured":"Dai X, Liang Z, Liu L et al (2019) Silencing of MALAT1 inhibits migration and invasion by sponging miR-1-3p in prostate cancer cells. Mole Med Report 20(4):3499\u20133508","journal-title":"Mole Med Report"},{"key":"4497_CR106","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109666","author":"T Hao","year":"2020","unstructured":"Hao T, Wang Z, Yang J et al (2020) MALAT1 knockdown inhibits prostate cancer progression by regulating miR-140\/BIRC6 axis. Biomed Pharmacotherap Biomed Pharmacotherap. https:\/\/doi.org\/10.1016\/j.biopha.2019.109666","journal-title":"Biomed Pharmacotherap Biomed Pharmacotherap"},{"issue":"38","key":"4497_CR107","doi-asserted-by":"publisher","first-page":"41045","DOI":"10.18632\/oncotarget.5728","volume":"6","author":"D Wang","year":"2015","unstructured":"Wang D, Ding L, Wang L et al (2015) LncRNA MALAT1 enhances oncogenic activities of EZH2 in castration-resistant prostate cancer. Oncotarget 6(38):41045\u201341055","journal-title":"Oncotarget"},{"key":"4497_CR108","doi-asserted-by":"publisher","first-page":"8693259","DOI":"10.1155\/2022\/8693259","volume":"2022","author":"X Mu","year":"2022","unstructured":"Mu X, Shen Z, Lin Y et al (2022) LncRNA-MALAT1 regulates cancer glucose metabolism in prostate cancer via MYBL2\/mTOR axis. Oxid Med Cell Longev 2022:8693259","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"4497_CR109","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1038\/s41416-020-01091-1","volume":"124","author":"T Li","year":"2021","unstructured":"Li T, Liu N, Gao Y et al (2021) Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM. Br J Cancer 124(1):247\u2013258","journal-title":"Br J Cancer"},{"issue":"9","key":"4497_CR110","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1038\/s41401-019-0234-8","volume":"40","author":"JJ Zhang","year":"2019","unstructured":"Zhang JJ, Zhou XH, Zhou Y et al (2019) Bufalin suppresses the migration and invasion of prostate cancer cells through HOTAIR, the sponge of miR-520b. Acta Pharmacol Sin 40(9):1228\u20131236","journal-title":"Acta Pharmacol Sin"},{"issue":"13","key":"4497_CR111","doi-asserted-by":"publisher","first-page":"12771","DOI":"10.18632\/aging.103188","volume":"12","author":"N Wang","year":"2020","unstructured":"Wang N, Jiang Y, Lv S et al (2020) HOTAIR expands the population of prostatic cancer stem-like cells and causes Docetaxel resistance via activating STAT3 signaling. Aging 12(13):12771\u201312782","journal-title":"Aging"},{"issue":"1","key":"4497_CR112","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.celrep.2015.08.069","volume":"13","author":"A Zhang","year":"2015","unstructured":"Zhang A, Zhao JC, Kim J et al (2015) LncRNA HOTAIR enhances the androgen-receptor-mediated transcriptional program and drives castration-resistant prostate cancer. Cell Rep 13(1):209\u2013221","journal-title":"Cell Rep"},{"key":"4497_CR113","doi-asserted-by":"publisher","first-page":"5383","DOI":"10.1038\/ncomms6383","volume":"5","author":"D Chakravarty","year":"2014","unstructured":"Chakravarty D, Sboner A, Nair SS et al (2014) The oestrogen receptor alpha-regulated lncRNA NEAT1 is a critical modulator of prostate cancer. Nat Commun 5:5383","journal-title":"Nat Commun"},{"key":"4497_CR114","first-page":"1866972","volume":"2022","author":"W Zhao","year":"2022","unstructured":"Zhao W, Zhu X, Jin Q et al (2022) The lncRNA NEAT1\/miRNA-766-5p\/E2F3 regulatory axis promotes prostate cancer progression. J Oncol 2022:1866972","journal-title":"J Oncol"},{"issue":"2","key":"4497_CR115","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s10616-023-00612-z","volume":"76","author":"W Xu","year":"2024","unstructured":"Xu W, Wu Y, Zhang G (2024) NEAT1 promotes the progression of prostate cancer by targeting the miR-582-5p\/EZH2 regulatory axis. Cytotechnology 76(2):231\u2013246","journal-title":"Cytotechnology"},{"issue":"1","key":"4497_CR116","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12943-020-01293-4","volume":"19","author":"S Wen","year":"2020","unstructured":"Wen S, Wei Y, Zen C et al (2020) Long non-coding RNA NEAT1 promotes bone metastasis of prostate cancer through N6-methyladenosine. Mol Cancer 19(1):171","journal-title":"Mol Cancer"},{"key":"4497_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2019.109422","volume":"65","author":"X Jiang","year":"2020","unstructured":"Jiang X, Guo S, Zhang Y et al (2020) LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p. Cell Signal 65:109422","journal-title":"Cell Signal"},{"key":"4497_CR118","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12483","author":"W Weng","year":"2021","unstructured":"Weng W, Liu C, Li G et al (2021) Long non\u2013coding RNA SNHG16 functions as a tumor activator by sponging miR-373-3p to regulate the TGF-\u03b2-R2\/SMAD pathway in prostate cancer. Molecul Med Report. https:\/\/doi.org\/10.3892\/mmr.2021.12483","journal-title":"Molecul Med Report"},{"key":"4497_CR119","first-page":"1751","volume":"12","author":"M Shao","year":"2020","unstructured":"Shao M, Yu Z, Zou J (2020) LncRNA-SNHG16 silencing inhibits prostate carcinoma cell growth, downregulate Glut1 expression and reduce glucose uptake. Can Manag Res 12:1751\u20131757","journal-title":"Can Manag Res"},{"issue":"1","key":"4497_CR120","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1186\/s13046-024-03233-2","volume":"43","author":"J Kallenbach","year":"2024","unstructured":"Kallenbach J, Rasa M, Heidari Horestani M et al (2024) The oncogenic lncRNA MIR503HG suppresses cellular senescence counteracting supraphysiological androgen treatment in prostate cancer. J Experim ClinCancer Res 43(1):321","journal-title":"J Experim ClinCancer Res"},{"issue":"18","key":"4497_CR121","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1016\/j.jacc.2015.07.081","volume":"66","author":"J Fiedler","year":"2015","unstructured":"Fiedler J, Breckwoldt K, Remmele CW et al (2015) Development of long noncoding rna-based strategies to modulate tissue vascularization. J Am Coll Cardiol 66(18):2005\u20132015","journal-title":"J Am Coll Cardiol"},{"issue":"10","key":"4497_CR122","doi-asserted-by":"publisher","first-page":"4245","DOI":"10.1172\/JCI127613","volume":"129","author":"P Chatterjee","year":"2019","unstructured":"Chatterjee P, Schweizer MT, Lucas JM et al (2019) Supraphysiological androgens suppress prostate cancer growth through androgen receptor-mediated DNA damage. J Clin Investig 129(10):4245\u20134260","journal-title":"J Clin Investig"},{"issue":"1","key":"4497_CR123","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/s41391-022-00636-0","volume":"26","author":"MT Schweizer","year":"2023","unstructured":"Schweizer MT, Gulati R, Yezefski T et al (2023) Bipolar androgen therapy plus olaparib in men with metastatic castration-resistant prostate cancer. Prostate Cancer Prostatic Dis 26(1):194\u2013200","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"4497_CR124","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1016\/j.cell.2015.10.025","volume":"163","author":"A Abeshouse","year":"2015","unstructured":"Abeshouse A, Ahn J, Akbani R et al (2015) The molecular taxonomy of primary prostate cancer. Cell 163(4):1011\u20131025","journal-title":"Cell"},{"issue":"1","key":"4497_CR125","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1186\/s12967-025-06294-9","volume":"23","author":"Y Wu","year":"2025","unstructured":"Wu Y, Cheng S, Zhang T et al (2025) A novel lncRNA FLJ promotes castration resistance in prostate cancer through AR mediated autophagy. J Transl Med 23(1):255","journal-title":"J Transl Med"},{"issue":"19","key":"4497_CR126","doi-asserted-by":"publisher","first-page":"5464","DOI":"10.7150\/thno.33282","volume":"9","author":"J Jia","year":"2019","unstructured":"Jia J, Zhang HB, Shi Q et al (2019) KLF5 downregulation desensitizes castration-resistant prostate cancer cells to docetaxel by increasing BECN1 expression and inducing cell autophagy. Theranostics 9(19):5464\u20135477","journal-title":"Theranostics"},{"issue":"6","key":"4497_CR127","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41374-022-00736-4","volume":"102","author":"Z Xing","year":"2022","unstructured":"Xing Z, Li S, Xing J et al (2022) Silencing of LINC01963 enhances the chemosensitivity of prostate cancer cells to docetaxel by targeting the miR-216b-5p\/TrkB axis. Laborat Investigat J Tech Method Pathol 102(6):602\u2013612","journal-title":"Laborat Investigat J Tech Method Pathol"},{"key":"4497_CR128","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/112_2017_6","volume":"174","author":"J Meldolesi","year":"2018","unstructured":"Meldolesi J (2018) Neurotrophin Trk receptors: new targets for cancer therapy. Rev Physiol Biochem Pharmacol 174:67\u201379","journal-title":"Rev Physiol Biochem Pharmacol"},{"issue":"1","key":"4497_CR129","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s10565-024-09985-z","volume":"41","author":"W Zhuang","year":"2024","unstructured":"Zhuang W, Xu S, He Q et al (2024) RBM19 promotes the progression of prostate cancer under docetaxel treatment via SNHG21\/PIM1 axis. Cell Biol Toxicol 41(1):19","journal-title":"Cell Biol Toxicol"},{"issue":"5","key":"4497_CR130","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1080\/15384047.2020.1727700","volume":"21","author":"X Li","year":"2020","unstructured":"Li X, Han X, Wei P et al (2020) Knockdown of lncRNA CCAT1 enhances sensitivity of paclitaxel in prostate cancer via regulating miR-24-3p and FSCN1. Cancer Biol Ther 21(5):452\u2013462","journal-title":"Cancer Biol Ther"},{"issue":"12","key":"4497_CR131","doi-asserted-by":"publisher","first-page":"2469","DOI":"10.1158\/1535-7163.MCT-19-0095","volume":"18","author":"Z You","year":"2019","unstructured":"You Z, Liu C, Wang C et al (2019) LncRNA CCAT1 promotes prostate cancer cell proliferation by interacting with DDX5 and MIR-28-5P. Mol Cancer Ther 18(12):2469\u20132479","journal-title":"Mol Cancer Ther"},{"issue":"5","key":"4497_CR132","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1002\/1878-0261.12471","volume":"13","author":"A Parolia","year":"2019","unstructured":"Parolia A, Venalainen E, Xue H et al (2019) The long noncoding RNA HORAS5 mediates castration-resistant prostate cancer survival by activating the androgen receptor transcriptional program. Mol Oncol 13(5):1121\u20131136","journal-title":"Mol Oncol"},{"issue":"13","key":"4497_CR133","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.2217\/epi-2019-0316","volume":"12","author":"P Pucci","year":"2020","unstructured":"Pucci P, Venalainen E, Alborelli I et al (2020) LncRNA HORAS5 promotes taxane resistance in castration-resistant prostate cancer via a BCL2A1-dependent mechanism. Epigenomics 12(13):1123\u20131138","journal-title":"Epigenomics"},{"issue":"8","key":"4497_CR134","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/j.neo.2016.07.001","volume":"18","author":"S Shukla","year":"2016","unstructured":"Shukla S, Zhang X, Niknafs YS et al (2016) Identification and validation of PCAT14 as prognostic biomarker in prostate cancer. Neoplasia (New York, NY) 18(8):489\u2013499","journal-title":"Neoplasia (New York, NY)"},{"key":"4497_CR135","doi-asserted-by":"publisher","first-page":"1659","DOI":"10.2147\/OTT.S288785","volume":"14","author":"H Hao","year":"2021","unstructured":"Hao H, Chen H, Xie L et al (2021) LncRNA KCNQ1OT1 promotes proliferation, invasion and metastasis of prostate cancer by regulating miR-211-5p\/CHI3L1 Pathway. Onco Targets Ther 14:1659\u20131671","journal-title":"Onco Targets Ther"},{"key":"4497_CR136","doi-asserted-by":"publisher","DOI":"10.1016\/j.scitotenv.2022.157252","author":"Y Wang","year":"2022","unstructured":"Wang Y, Guo Y, Lu Y et al (2022) The effects of endosulfan on cell migration and invasion in prostate cancer cells via the KCNQ1OT1\/miR-137\u20133p\/PTP4A3 axis. Sci Total Environ. https:\/\/doi.org\/10.1016\/j.scitotenv.2022.157252","journal-title":"Sci Total Environ"},{"key":"4497_CR137","doi-asserted-by":"publisher","first-page":"9494619","DOI":"10.1155\/2021\/9494619","volume":"2021","author":"Y Yan","year":"2021","unstructured":"Yan Y, Liu J, Xu Z et al (2021) lncRNA PCAT14 is a diagnostic marker for prostate cancer and is associated with immune cell infiltration. Dis Markers 2021:9494619","journal-title":"Dis Markers"},{"issue":"10","key":"4497_CR138","first-page":"1613","volume":"1832","author":"MR Pickard","year":"2013","unstructured":"Pickard MR, Mourtada-Maarabouni M, Williams GT (2013) Long non-coding RNA GAS5 regulates apoptosis in prostate cancer cell lines. Biochem Biophys Acta 1832(10):1613\u20131623","journal-title":"Biochem Biophys Acta"},{"issue":"6","key":"4497_CR139","doi-asserted-by":"publisher","first-page":"643","DOI":"10.4103\/aja2021117","volume":"24","author":"TT Lu","year":"2022","unstructured":"Lu TT, Tao X, Li HL et al (2022) LncRNA GAS5 enhances tumor stem cell-like medicated sensitivity of paclitaxel and inhibits epithelial-to-mesenchymal transition by targeting the miR-18a-5p\/STK4 pathway in prostate cancer. Asian J Androl 24(6):643\u2013652","journal-title":"Asian J Androl"},{"key":"4497_CR140","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.675215","volume":"11","author":"Y Shan","year":"2021","unstructured":"Shan Y, Huang Y, Lee AM et al (2021) A long noncoding RNA, GAS5 can be a biomarker for docetaxel response in castration resistant prostate cancer. Front Oncol 11:675215","journal-title":"Front Oncol"},{"key":"4497_CR141","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2015.00283","author":"IA Asteriti","year":"2015","unstructured":"Asteriti IA, De Mattia F, Guarguaglini G (2015) Cross-talk between aurka and plk1 in mitotic entry and spindle assembly. Front Oncol. https:\/\/doi.org\/10.3389\/fonc.2015.00283","journal-title":"Front Oncol"},{"issue":"8","key":"4497_CR142","doi-asserted-by":"publisher","first-page":"1959","DOI":"10.1016\/j.ymthe.2017.04.016","volume":"25","author":"P Gu","year":"2017","unstructured":"Gu P, Chen X, Xie R et al (2017) lncRNA HOXD-AS1 regulates proliferation and chemo-resistance of castration-resistant prostate cancer via recruiting WDR5. Mol Ther 25(8):1959\u20131973","journal-title":"Mol Ther"},{"issue":"9","key":"4497_CR143","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/pros.22987","volume":"75","author":"Y Liu","year":"2015","unstructured":"Liu Y, Liu X, Guo Y et al (2015) Methylselenocysteine preventing castration-resistant progression of prostate cancer. Prostate 75(9):1001\u20131008","journal-title":"Prostate"},{"key":"4497_CR144","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.865350","volume":"12","author":"J Huang","year":"2022","unstructured":"Huang J, Lin B, Li B (2022) Anti-androgen receptor therapies in prostate cancer: a brief update and perspective. Front Oncol 12:865350","journal-title":"Front Oncol"},{"issue":"10336","key":"4497_CR145","doi-asserted-by":"publisher","first-page":"1695","DOI":"10.1016\/S0140-6736(22)00367-1","volume":"399","author":"K Fizazi","year":"2022","unstructured":"Fizazi K, Foulon S, Carles J et al (2022) Abiraterone plus prednisone added to androgen deprivation therapy and docetaxel in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 \u00d7 2 factorial design. Lancet (London, England) 399(10336):1695\u20131707","journal-title":"Lancet (London, England)"},{"issue":"2","key":"4497_CR146","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/j.ijrobp.2022.01.037","volume":"113","author":"AY Jia","year":"2022","unstructured":"Jia AY, Spratt DE (2022) Bicalutamide monotherapy with radiation therapy for localized prostate cancer: a non-evidence-based alternative. Int J Radiat Oncol Biol Phys 113(2):316\u2013319","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"4497_CR147","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA et al (2023) Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Upd Rev Comment Antimicro Antican Chemother 68:100962","journal-title":"Drug Resist Upd Rev Comment Antimicro Antican Chemother"},{"issue":"7","key":"4497_CR148","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.7150\/jca.65329","volume":"13","author":"J Xie","year":"2022","unstructured":"Xie J, Chen X, Wang W et al (2022) Long non-coding RNA PCDRlnc1 confers docetaxel resistance in prostate cancer by promoting autophagy. J Cancer 13(7):2138\u20132149","journal-title":"J Cancer"},{"issue":"5","key":"4497_CR149","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s00280-016-3158-8","volume":"78","author":"X Wang","year":"2016","unstructured":"Wang X, Yang B, Ma B (2016) The UCA1\/miR-204\/Sirt1 axis modulates docetaxel sensitivity of prostate cancer cells. Cancer Chemother Pharmacol 78(5):1025\u20131031","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"4497_CR150","doi-asserted-by":"publisher","first-page":"120","DOI":"10.26444\/aaem\/96331","volume":"26","author":"G Surdacki","year":"2019","unstructured":"Surdacki G, Szudy-Szczyrek A, Gor\u0105cy A et al (2019) The role of immune checkpoint inhibitors in prostate cancer. Ann Agricul Environ Med 26(1):120\u2013124","journal-title":"Ann Agricul Environ Med"},{"key":"4497_CR151","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1186\/s12935-020-01481-8","volume":"20","author":"QH Chen","year":"2020","unstructured":"Chen QH, Li B, Liu DG et al (2020) LncRNA KCNQ1OT1 sponges miR-15a to promote immune evasion and malignant progression of prostate cancer via up-regulating PD-L1. Cancer Cell Int 20:394","journal-title":"Cancer Cell Int"},{"issue":"34","key":"4497_CR152","doi-asserted-by":"publisher","first-page":"57755","DOI":"10.18632\/oncotarget.17645","volume":"8","author":"W Ma","year":"2017","unstructured":"Ma W, Chen X, Ding L et al (2017) The prognostic value of long noncoding RNAs in prostate cancer: a systematic review and meta-analysis. Oncotarget 8(34):57755\u201357765","journal-title":"Oncotarget"},{"key":"4497_CR153","doi-asserted-by":"publisher","first-page":"8833","DOI":"10.2147\/CMAR.S244123","volume":"12","author":"X Ma","year":"2020","unstructured":"Ma X, Wang Z, Ren H et al (2020) Long non-coding RNA GAS5 suppresses tumor progression and enhances the radiosensitivity of prostate cancer through the miR-320a\/RAB21 axis. Cancer Manag Res 12:8833\u20138845","journal-title":"Cancer Manag Res"},{"issue":"18","key":"4497_CR154","doi-asserted-by":"publisher","first-page":"3728","DOI":"10.1158\/0008-5472.CAN-15-0273","volume":"75","author":"J Li","year":"2015","unstructured":"Li J, Han L, Roebuck P et al (2015) Tanric: an interactive open platform to explore the function of lncRNAs in cancer. Can Res 75(18):3728\u20133737","journal-title":"Can Res"},{"issue":"12","key":"4497_CR155","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1038\/emboj.2011.154","volume":"30","author":"Z Chen","year":"2011","unstructured":"Chen Z, Zhang C, Wu D et al (2011) Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J 30(12):2405\u20132419","journal-title":"EMBO J"},{"issue":"13","key":"4497_CR156","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1080\/15384101.2015.1041689","volume":"14","author":"Z Zhang","year":"2015","unstructured":"Zhang Z, Chen L, Wang H et al (2015) Inhibition of Plk1 represses androgen signaling pathway in castration-resistant prostate cancer. Cell cycle (Georgetown, Tex) 14(13):2142\u20132148","journal-title":"Cell cycle (Georgetown, Tex)"},{"issue":"3","key":"4497_CR157","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s13277-011-0291-1","volume":"33","author":"Z Hao","year":"2012","unstructured":"Hao Z, Zhang H, Cowell J (2012) Ubiquitin-conjugating enzyme UBE2C: molecular biology, role in tumorigenesis, and potential as a biomarker. Tum Biol J Intern Soc Oncodevelop Med 33(3):723\u2013730","journal-title":"Tum Biol J Intern Soc Oncodevelop Med"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04497-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04497-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04497-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T15:07:13Z","timestamp":1759849633000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04497-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,23]]},"references-count":157,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["4497"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04497-z","relation":{"references":[{"id-type":"doi","id":"10.1042\/BSR20181465","asserted-by":"subject"}]},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,23]]},"assertion":[{"value":"22 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}